Symptomatic use of beclomethasone plus albuterol and regular use of beclomethasone did not differ for control of mild asthma

November 2007
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p64
Academic Journal
The article offers information on a study, investigating whether the symptomatic use of beclomethasone and albuterol in combination, is as effective as regular use of the same dose of beclomethasone, for asthma patients. It describes the randomized controlled trials, setting, and the patient's condition for the study. The study revealed that the combined beclomethasone and albuterol did not differ from daily use of beclomethasone with as-needed albuterol for control of asthma.


Related Articles

  • COMMENTARY: Symptomatic use of beclomethasone plus albuterol and regular use of beclomethasone did not differ for control of mild asthma. Rees, P. John // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p64 

    The author reflects upon a study investigating whether the symptomatic use of beclomethasone and albuterol in combination, is as effective as regular use of the same dose of beclomethasone, for the asthma patients. He states that the study is a challenge to the importance of regular suppressive...

  • Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial. Papi, Alberto; Nicolini, Gabriele; Crimi, Nunzio; Fabbri, Leonardo; Olivieri, Dario; Rossi, Andrea; Paggiaro, Pierluigi // Respiratory Research;Jun2012, Vol. 13 Issue 6, p1 

    Background: Asthma guidelines suggest that therapy can be reduced once asthma is controlled. Despite these recommendations, asthmatic patients are seldom stepped down in clinical practice, and questions remain about when and how to reduce asthma therapy. The purpose of the present study was to...

  • Extrafine HFA-beclomethasone dipropionate versus budesonide for asthma: a meta-analysis. Xin Chen; Yingbo Kang; Liqing Wang; Lin Lin; Zhe Zhu; Rui Chen // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 1, p212 

    The small-particle inhaled corticosteroid might be a new available way to treat uncontrolled asthma. To evaluate the efficacy and safety of extrafine hydrofluoroalkane-beclomethasone dipropionate (HFA-BDP) versus budesonide (BUD) in patients with asthma, a meta-analysis was performed. A...

  • The Cost Effectiveness of Chlorofluorocarbon-Free Beclomethasone Dipropionate in the Treatment of Chronic Asthma: A Cost Model Based on a 1-Year Pragmatic, Randomised Clinical Study. Price, D.; Haughney, J.; Duerden, M.; Nicholls, C.; Moseley, C. // PharmacoEconomics;2002, Vol. 20, p653 

    Objective: To compare the cost effectiveness of hydrofluoroalkane 134a-beclomethasone dipropionate (HFA-BDP; Qvarâ„¢) with chlorofluorocarbon-beclomethasone dipropionate (CFC-BDP) in patients with chronic stable asthma previously receiving CFC-BDP, from the perspective of a healthcare...

  • Comparison of a Multidose Powder Inhaler Containing Beclomethasone Dipropionate (BDP) with a BDP Metered Dose Inhaler with Spacer in the Treatment of Asthmatic Patients. Lähelmä, S.; Poukkula, A.; Paananen, M.; Alanko, K.; Ruotsalainen E.-M.; Kilpiö, K.; Salomaa E.-R.; Knuuttila, A.; Silvasti, M.; Koskinen, S.; Suuronen, U.; Laitinen, J.; Toivanen, P.; Lehtonen, K.; Vilkka, V.; Liippo, K.; Lindqvist, A. // Clinical Drug Investigation;1998, Vol. 16 Issue 2, p101 

    Objective: The clinical efficacy, tolerability and acceptability of a new multidose powder inhaler (MDPI) [Easyhaler, Orion Pharma, Finland] containing a high dose (500 µg/dose) of beclomethasone dipropionate (BDP) were compared with those of BDP metered dose inhaler administered with a large...

  • Inhaled Corticosteroids for Pulmonary Disease.  // American Family Physician;10/1/1993, Vol. 48 Issue 5, p906 

    Determines whether progression of asthma or chronic obstructive pulmonary disease could be slowed by addition of treatment with inhaled corticosteroids. Study by Dompeling and colleagues published in the Annals of Internal Medicine, May 15, 1993 issue; Bronchodilator therapy and beclomethasone...

  • Beclomethasone Dipropionate. Williams, M. Henry // Annals of Internal Medicine;Oct81, Vol. 95 Issue 4, p464 

    Examines the results of the clinical trial on the application of beclomethasone dipropionate, an active corticosteroid in treating asthma. Approval in the use of the corticosteroid in the U.S.; Dosage and timing of the treatment; Long-term effects on the patients.

  • PHARMACOLOGICAL AND BIO - MOLECULAR INVESTIGATION OF CURCUMIN FOR ITS ANTI-ASTHMATIC ACTIVITY. Antony, A. Shanish; Krishna, P. Ramya; Sindhu, V.; Khan, Humair; Bhagheeradha, L.; Vadivelan, R.; Kumar, M. N. Satish; Elango, K.; Suresh, B. // Advances in Pharmacology & Toxicology;Apr2012, Vol. 13 Issue 1, p1 

    Curcumin has been ethnopharmacologically documented for its use in respiratory and inflammatory ailments. To investigate the effect of curcumin on bio-molecular parameters involved in asthma in rats. Experimental asthma was induced in rats by sensitization with ovalbumin (OVA) in all groups...

  • Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: Retrospective... Pethica, B.D.; Penrose, A. // BMJ: British Medical Journal (International Edition);10/10/98, Vol. 317 Issue 7164, p986 

    Studies the potency of inhaled budesonide and beclomethasone in the treatment of asthma in primary care. Evidence of the potency of budesonide compared to beclomethasone in primary care in New Zealand; Methodology of the study; Results of the study; Suggestion that the asthma treatment...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics